Delivery Order SPE2DR25D3404-SPE2DR26F5T2S
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Progesterone 200 mg capsules (100-count units) valued at $5,087.94 with firm fixed pricing. This non-competitive delivery order is set to conclude on September 24, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical supply vendor, fulfills...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Progesterone 200 mg capsules (100-count units) with a contract ceiling value of $7,427.51. This firm fixed-price delivery order, with an ultimate completion date of August 25, 2025, represents a competitively awarded, non-set-aside contract executed through AmerisourceBergen's existing pharmaceutical supply vehicle with the federal government. The product will be delivered...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 10, 2025, for the supply of Progesterone 200 mg capsules (100-count units) with a ceiling value of $15,414.75. This firm fixed-price delivery order, with an ultimate completion date of November 12, 2025, represents a non-competitive set-aside contract and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 11, 2025, for the supply of Progesterone 200 mg capsules (100-count units) with a ceiling value of $3,200.98. This is a firm fixed-price delivery order with an ultimate completion date of November 12, 2025, and no set-aside designation was used. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $4,585.97 to AmerisourceBergen Drug Corp for the supply of Progesterone 200 mg capsules (30-count units) on November 13, 2025, with completion expected by November 14, 2025. This firm fixed-price, non-set-aside contract is classified as a delivery order, indicating it was issued under a larger indefinite delivery vehicle. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 7, 2025, for the supply of Progesterone 200 mg capsules (100-count units) valued at $2,317.34. This contract is a firm fixed-price delivery order with an ultimate completion date of November 10, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 7, 2025, for the supply of Progesterone 200 mg capsules (100-count units) with a ceiling value of $5,503.28. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The order is scheduled for ultimate completion by November 10, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Progesterone 200 mg capsules (100-count units) on October 21, 2025, with an ultimate completion date of October 22, 2025. This competitively awarded, firm fixed-price delivery order has a ceiling value of $5,700.75 and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation and represents a child order under the company's...
- The Defense Logistics Agency awarded a competitive delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Progesterone 200 mg capsules (100-count units) with a contract ceiling value of $21,383.94. This is a firm fixed-price delivery order with an ultimate completion date of September 19, 2025, and represents a non-set-aside award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania—which is also the place of performance—is a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Progesterone 200 mg capsules (100 count) with a ceiling value of $4,508.52. This is a firm fixed price delivery order issued under a non-competitive, non-set-aside contract vehicle, with an ultimate completion date of August 19, 2025. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains significant...
- SPE2DR25D3404Indefinite Delivery Contract
- SPE2DR25D3404-SPE2DR26F5T2SDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Progesterone 200 mg capsules (100-count units) with a contract ceiling value of $8,036.91. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of November 14, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vehicle running through December 2026 that serves as a comprehensive global pharmaceutical support mechanism for military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was competitively selected for this award based on its established capability to meet federal procurement requirements for pharmaceutical products and medical supplies. The company's federal contract portfolio demonstrates extensive experience delivering a broad range of medical commodities to military and veteran healthcare systems, including specialty medications, generic and brand-name drugs, vaccines, and medical devices across multiple therapeutic domains. This delivery order represents a routine procurement of hormone treatment medication to support federal healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.0k | 11/13/25 |